Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy [Phase 2]
A Phase 2 trial evaluating the combination of Benmelstobart, Anlotinib, and SBRT for hepatocellular carcinoma patients who failed first-line…
-
CLINICAL_TRIALS other · 2026-04-17Clinical Trial Update: Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer [Phase 3]
Phase 3 clinical trial evaluating local consolidation after treatment with Sintilimab plus Lenvatinib for metastatic liver cancer; the study…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma [NA]
A clinical trial protocol evaluating Firsekibart, Tislelizumab, and Lenvatinib in unresectable hepatocellular carcinoma with TP53 mutation; …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating targeting ischemia-induced autophagy dependence in hepatocellular carcinoma is currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Combination of TATE and PD-1 Inhibitor in Liver Cancer [Phase 2]
Phase 2 clinical trial updating on the combination of TATE and a PD-1 inhibitor for hepatocellular carcinoma and gastric cancer, currently r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Patient Preference for Subcutaneous vs. Intravenous Immune Therapy [Phase 2]
Phase 2 clinical trial update on patient preference for subcutaneous versus intravenous immune therapy; the study is currently recruiting ac…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function [Phase 1]
Phase 1 study evaluating radiation therapy for patients with hepatocellular carcinoma, cholangiocarcinoma, or liver metastases who have impa…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
ClinicalTrials.gov update announcing an actively recruiting study of chronic liver diseases associated with alcohol use and metabolic syndro…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Scout Dose of Resin Microspheres [NA]
This trial update notes that a Scout dose study of resin microspheres is recruiting for liver-directed radioembolization in hepatocellular c…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment. [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating the combination of IBI310 and Sintilimab as first-line therapy for hepatocellular carcinoma and is …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma [Phase 3]
A Phase 3 global trial is evaluating transarterial chemoembolization combined with durvalumab and bevacizumab for locoregional hepatocellula…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
An observational study to evaluate how well a subsequent treatment works in adults with unresectable hepatocellular carcinoma after prior th…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Radioembolization Versus External Radiation Therapy [Phase 2]
A Phase 2 clinical trial is comparing radioembolization to external beam radiation therapy for hepatocellular carcinoma. The study is curren…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
This clinical trial update discusses an MD Anderson Cancer Center study evaluating a 'Teaching the Teachers' concept to improve global educa…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis [NA]
This update describes a study that uses surveys, blood testing, and FibroScan to screen for liver fibrosis and liver cirrhosis in patients w…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer [Phase 1]
Phase 1 pilot study evaluating the clinical utility of Pylarify PET-CT for detecting metastasis in pancreatic cancer, hepatocellular carcino…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma [Phase 1]
Phase 1 trial evaluating autologous GPC3-targeted CAR T cells (RPCAR01) for advanced or metastatic hepatocellular carcinoma; the study statu…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer [Phase 1]
A first-in-human Phase 1 study to evaluate the safety and initial activity of BAY 3547926 in adults with advanced hepatocellular carcinoma. …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma [Phase 3]
A Phase 3 study is recruiting to evaluate the combination of transarterial chemoembolization (TACE) with camrelizumab and apatinib in patien…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]
The clinical trial of T-ACE Oil for hepatocellular carcinoma (Phase 1/Phase 2) is currently suspended.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial [Phase 3]
Phase 3 trial assessing whether aspirin can reduce the risk of hepatocellular carcinoma in patients with liver cirrhosis; the AspiRe HCC Tri…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) [Phase 1, Phase 2]
A clinical trial evaluating the safety and tolerability of Pumitamig alone or in combination with ipilimumab in first-line advanced or unres…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of ZW251 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update notes a study of ZW251 in participants with advanced solid tumors, including hepatocellular carcinoma, non-small c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma [Phase 2]
This Phase 2 trial compares STRIDE (durvalumab plus tremelimumab) with lenvatinib versus STRIDE alone in unresectable hepatocellular carcino…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
A recruiting clinical study uses single-cell multiomics and spatiotemporal omics to investigate mechanisms of liver degeneration. Sponsored …